(Q36382217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

0 references

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Patrizia Formichi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Carla Battisti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Elena Radi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

1 reference

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Physiology

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

39-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.

16 January 2020

cites work

1 reference

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

21 January 2018

1 reference

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

21 January 2018

1 reference

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

21 January 2018

1 reference

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

21 January 2018

1 reference

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

21 January 2018

1 reference

Cerebrometabolic abnormalities in Alzheimer's disease

21 January 2018

1 reference

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

21 January 2018

1 reference

Combined analysis of CSF betaA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data

21 January 2018

1 reference

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.

21 January 2018

1 reference

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

21 January 2018

1 reference

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

21 January 2018

1 reference

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

21 January 2018

1 reference

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

21 January 2018

1 reference

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

Tau protein and the neurofibrillary pathology of Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.

21 January 2018

1 reference

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules

21 January 2018

1 reference

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

21 January 2018

1 reference

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

21 January 2018

1 reference

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

21 January 2018

1 reference

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay

21 January 2018

1 reference

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

Tau pathology in Alzheimer disease and other tauopathies

21 January 2018

1 reference

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

21 January 2018

1 reference

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination.

21 January 2018

1 reference

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

21 January 2018

1 reference

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

21 January 2018

1 reference

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

21 January 2018

1 reference

O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease

21 January 2018

1 reference

The molecular bases of Alzheimer's disease and other neurodegenerative disorders

21 January 2018

1 reference

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

21 January 2018

1 reference

Tau domains, phosphorylation, and interactions with microtubules.

21 January 2018

1 reference

Increased cerebrospinal fluid cAMP levels in Alzheimer's disease.

21 January 2018

1 reference

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

21 January 2018

1 reference

Increased tau protein level in postmortem cerebrospinal fluid.

21 January 2018

1 reference

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

21 January 2018

1 reference

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

1 reference

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia

21 January 2018

1 reference

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

21 January 2018

1 reference

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

21 January 2018

1 reference

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

21 January 2018

1 reference

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

21 January 2018

1 reference

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

21 January 2018

1 reference

Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

21 January 2018

1 reference

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

21 January 2018

1 reference

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

21 January 2018

1 reference

Both total and phosphorylated tau are increased in Alzheimer's disease

21 January 2018

1 reference

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment.

21 January 2018

1 reference

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

21 January 2018

1 reference

Tau protein pathology in neurodegenerative diseases.

21 January 2018

1 reference

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

21 January 2018

1 reference

AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

21 January 2018

1 reference

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

21 January 2018

1 reference

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

21 January 2018

1 reference

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

21 January 2018

1 reference

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

21 January 2018

1 reference

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

21 January 2018

1 reference

Tau Protein in Cerebrospinal Fluid

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.20602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16447254%20AND%20SRC:MED&resulttype=core&format=json

release_ojvyixjbnjdavfjbhork6t6e4e

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ojvyixjbnjdavfjbhork6t6e4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference